BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdo J, Cornell DL, Mittal SK, Agrawal DK. Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers. Front Oncol. 2018;8:85. [PMID: 29644213 DOI: 10.3389/fonc.2018.00085] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Kepp O, Marabelle A, Zitvogel L, Kroemer G. Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies. Nat Rev Clin Oncol 2020;17:49-64. [DOI: 10.1038/s41571-019-0272-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
2 Kodet O, Němejcova K, Strnadová K, Havlínová A, Dundr P, Krajsová I, Štork J, Smetana K Jr, Lacina L. The Abscopal Effect in the Era of Checkpoint Inhibitors. Int J Mol Sci 2021;22:7204. [PMID: 34281259 DOI: 10.3390/ijms22137204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhu B, Liu Y, Li J, Diao L, Shao L, Han-Zhang H, Zhang L, Kang Q, Yang W. Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report. Oncologist 2020;25:15-8. [PMID: 31848313 DOI: 10.1634/theoncologist.2019-0739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Zhu C, Lin S, Liang J, Zhu Y. PD-1 blockade enhances the anti-tumor immune response induced by cryoablation in a murine model of renal cell carcinoma. Cryobiology 2019;87:86-90. [DOI: 10.1016/j.cryobiol.2019.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Zhang T, Wang F, Wu JY, Qiu ZC, Wang Y, Liu F, Ge XS, Qi XW, Mao Y, Hua D. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. World J Gastroenterol 2018; 24(31): 3538-3546 [PMID: 30131660 DOI: 10.3748/wjg.v24.i31.3538] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
6 Venkatachalam S, McFarland TR, Agarwal N, Swami U. Immune Checkpoint Inhibitors in Prostate Cancer. Cancers (Basel) 2021;13:2187. [PMID: 34063238 DOI: 10.3390/cancers13092187] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 De Tommasi F, Massaroni C, Grasso RF, Carassiti M, Schena E. Temperature Monitoring in Hyperthermia Treatments of Bone Tumors: State-of-the-Art and Future Challenges. Sensors (Basel) 2021;21:5470. [PMID: 34450911 DOI: 10.3390/s21165470] [Reference Citation Analysis]
8 Patel D, McKay R, Parsons JK. Immunotherapy for Localized Prostate Cancer: The Next Frontier? Urol Clin North Am 2020;47:443-56. [PMID: 33008495 DOI: 10.1016/j.ucl.2020.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Habrawi Z, Melkus MW, Khan S, Henderson J, Brandi L, Chu V, Layeequr Rahman R. Cryoablation: A promising non-operative therapy for low-risk breast cancer. Am J Surg 2021;221:127-33. [PMID: 32788081 DOI: 10.1016/j.amjsurg.2020.07.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Murali N, Ludwig JM, Nezami N, Kim HS. Oligometastatic Disease and Interventional Oncology: Rationale and Research Directions. Cancer J 2020;26:166-73. [PMID: 32205542 DOI: 10.1097/PPO.0000000000000442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Messmer MN, Snyder AG, Oberst A. Comparing the effects of different cell death programs in tumor progression and immunotherapy. Cell Death Differ 2019;26:115-29. [PMID: 30341424 DOI: 10.1038/s41418-018-0214-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
12 Bonichon F, de Baere T, Berdelou A, Leboulleux S, Giraudet AL, Cuinet M, Drui D, Liberge R, Kelly A, Tenenbaum F, Legmann P, Do Cao C, Leenhardt L, Toubeau M, Godbert Y, Palussière J. Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network. Endocrine 2021;72:798-808. [PMID: 33770383 DOI: 10.1007/s12020-020-02580-2] [Reference Citation Analysis]
13 Takada M, Toi M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol 2019;24:608-13. [PMID: 30982153 DOI: 10.1007/s10147-019-01448-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lugnani F, Zhao JG. Translation of Cryobiological Techniques to Socially Economically Deprived Populations—Part 2: Cryosurgery. Journal of Medical Devices 2020;14:010802. [DOI: 10.1115/1.4045836] [Reference Citation Analysis]
15 Baust JM, Robilotto A, Santucci KL, Snyder KK, Van Buskirk RG, Katz A, Corcoran A, Baust JG. Evaluation of a Novel Cystoscopic Compatible Cryocatheter for the Treatment of Bladder Cancer. BLC 2020;6:303-18. [DOI: 10.3233/blc-200321] [Reference Citation Analysis]
16 Korbelik M, Banáth J, Zhang W, Gallagher P, Hode T, Lam SSK, Chen WR. N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines. Int Immunopharmacol 2019;75:105764. [PMID: 31352327 DOI: 10.1016/j.intimp.2019.105764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jain NA, Otterson GA. Immunotherapy in inoperable stage III non-small cell lung cancer: a review. Drugs Context 2019;8:212578. [PMID: 31258616 DOI: 10.7573/dic.212578] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Chang EM, Shaverdian N, Capiro N, Steinberg ML, Raldow AC. Cost Effectiveness of External Beam Radiation Therapy versus Percutaneous Image-Guided Cryoablation for Palliation of Uncomplicated Bone Metastases. Journal of Vascular and Interventional Radiology 2020;31:1221-32. [DOI: 10.1016/j.jvir.2020.03.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Strome AL, Zhang X, Strome SE. The evolving role of immuno-oncology for the treatment of head and neck cancer. Laryngoscope Investig Otolaryngol 2019;4:62-9. [PMID: 30828620 DOI: 10.1002/lio2.235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Doshi A, Zhou M, Bui N, Wang DS, Ganjoo K, Hwang GL. Safety and Feasibility of Cryoablation during Immunotherapy in Patients with Metastatic Soft Tissue Sarcoma. J Vasc Interv Radiol 2021;32:1688-94. [PMID: 34478852 DOI: 10.1016/j.jvir.2021.08.017] [Reference Citation Analysis]
21 Shen L, Qi H, Chen S, Cao F, Xie L, Wu Y, Ma W, Song Z, Yuan H, Zhang T, Li D, Wen X, Chen Q, Li W, Zhang X, Fan W. Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study. Cancer Immunol Immunother 2020;69:1713-24. [PMID: 32333081 DOI: 10.1007/s00262-020-02566-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chung FT, Chou CL, Lo YL, Kuo CH, Wang TY, Wang CH, Huang HY, Lin HC, Chang CH, Lee CS, Chen HC, Lin SM. Factors affecting survival in patients with endobronchial malignant mass after flexible Bronchoscopic cryotherapy: a cohort study. BMC Pulm Med 2019;19:101. [PMID: 31126271 DOI: 10.1186/s12890-019-0854-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Regen-Tuero HC, Ward RC, Sikov WM, Littrup PJ. Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy. Radiol Imaging Cancer 2021;3:e200134. [PMID: 33817653 DOI: 10.1148/rycan.2021200134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Balakrishnan PB, Sweeney EE, Ramanujam AS, Fernandes R. Photothermal therapies to improve immune checkpoint blockade for cancer. Int J Hyperthermia 2020;37:34-49. [PMID: 33426992 DOI: 10.1080/02656736.2020.1797190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Gilmore E, McCabe N, Kennedy RD, Parkes EE. DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy. J Oncol 2019;2019:4325105. [PMID: 31320901 DOI: 10.1155/2019/4325105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang H, Shen K, Liu Y, Zhang Y, Liao Z, Zhu D, Ji Y, Wei X, Wang S. Some reflections on Engineering T cell response to cancer antigens by choice of focal therapeutic conditions. Int J Hyperthermia 2020;37:531-2. [PMID: 32458710 DOI: 10.1080/02656736.2020.1768299] [Reference Citation Analysis]
27 Qian L, Shen Y, Xie J, Meng Z. Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020;1874:188385. [DOI: 10.1016/j.bbcan.2020.188385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Zhang L, Xu L, Wang Y, Liu X, Zhang M, Li W. Antitumor Immunity Augmented by Combining Radiofrequency Ablation with Anti-CTLA-4 Therapy in a Subcutaneous Murine Hepatoma Model. J Vasc Interv Radiol 2020;31:1178-86. [PMID: 32534975 DOI: 10.1016/j.jvir.2020.01.022] [Reference Citation Analysis]
29 Wah TM, Zhong J, Wilson M, Vasudev NS, Banks RE. An Exploratory Analysis of Changes in Circulating Plasma Protein Profiles Following Image-Guided Ablation of Renal Tumours Provides Evidence for Effects on Multiple Biological Processes. Cancers (Basel) 2021;13:6037. [PMID: 34885149 DOI: 10.3390/cancers13236037] [Reference Citation Analysis]
30 Najafi M, Mortezaee K, Rahimifard M, Farhood B, Haghi-aminjan H. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study. Life Sciences 2020;257:118051. [DOI: 10.1016/j.lfs.2020.118051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
31 Pusceddu C, Paliogiannis P, Nigri G, Fancellu A. Cryoablation In The Management Of Breast Cancer: Evidence To Date. Breast Cancer (Dove Med Press) 2019;11:283-92. [PMID: 31632134 DOI: 10.2147/BCTT.S197406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Lakshmi BA, Kim YJ. Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications. Int J Mol Sci 2022;23:1641. [PMID: 35163563 DOI: 10.3390/ijms23031641] [Reference Citation Analysis]
33 Dumolard L, Ghelfi J, Roth G, Decaens T, Macek Jilkova Z. Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma. Int J Mol Sci. 2020;21. [PMID: 32575734 DOI: 10.3390/ijms21124398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Connor MJ, Shah TT, Horan G, Bevan CL, Winkler M, Ahmed HU. Cytoreductive treatment strategies for de novo metastatic prostate cancer. Nat Rev Clin Oncol 2020;17:168-82. [PMID: 31712648 DOI: 10.1038/s41571-019-0284-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
35 Baust JM, Santucci KL, Van Buskirk RG, Raijman I, Fisher WE, Baust JG, Snyder KK. An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line. Biomedicines 2022;10:450. [DOI: 10.3390/biomedicines10020450] [Reference Citation Analysis]
36 Yonezawa N, Murakami H, Demura S, Kato S, Miwa S, Yoshioka K, Shinmura K, Yokogawa N, Shimizu T, Oku N, Kitagawa R, Handa M, Annen R, Kurokawa Y, Fushimi K, Mizukoshi E, Tsuchiya H. Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model. Int J Mol Sci 2021;22:1973. [PMID: 33671258 DOI: 10.3390/ijms22041973] [Reference Citation Analysis]
37 Ross AE, Hurley PJ, Tran PT, Rowe SP, Benzon B, Neal TO, Chapman C, Harb R, Milman Y, Trock BJ, Drake CG, Antonarakis ES. A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer. Prostate Cancer Prostatic Dis 2020;23:184-93. [PMID: 31611635 DOI: 10.1038/s41391-019-0176-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
38 Hu J, Chen S, Wang X, Lin N, Yang J, Wu S. Image-Guided Percutaneous ‎Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results. Cancer Manag Res 2019;11:9801-11. [PMID: 31819618 DOI: 10.2147/CMAR.S227961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Li X, Xu J, Gu X, Chen L, Wu Q, Li H, Bai H, Yang J, Qian J. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma. Front Immunol 2021;12:740790. [PMID: 34733279 DOI: 10.3389/fimmu.2021.740790] [Reference Citation Analysis]
40 Venturini M, Cariati M, Marra P, Masala S, Pereira PL, Carrafiello G. CIRSE Standards of Practice on Thermal Ablation of Primary and Secondary Lung Tumours. Cardiovasc Intervent Radiol 2020;43:667-83. [PMID: 32095842 DOI: 10.1007/s00270-020-02432-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
41 Pozzessere C, Bouchaab H, Jumeau R, Letovanec I, Daccord C, Bourhis J, Prior JO, Peters S, Lazor R, Beigelman-Aubry C. Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study. ERJ Open Res 2020;6:00165-2019. [PMID: 32201690 DOI: 10.1183/23120541.00165-2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
42 Cano-Mejia J, Shukla A, Ledezma DK, Palmer E, Villagra A, Fernandes R. CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma. Transl Oncol 2020;13:100823. [PMID: 32652470 DOI: 10.1016/j.tranon.2020.100823] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]